Rosenstein J M
Department of Anatomy, The George Washington University Medical Center, Washington, DC 20037, USA.
Exp Neurol. 1996 Nov;142(1):66-79. doi: 10.1006/exnr.1996.0179.
In the present study solid grafts of rat fetal neocortex or substantia nigra were transplanted into young adult rat cortex or striatum. To study the permeability to protein and potential changes in the blood-brain barrier (BBB), HRP was administered intravascularly or, to examine endogenous protein exudation, noninjected animals were evaluated after immunocytochemical stain for rat serum albumin. In addition, [3H]GABA, a neurotransmitter that does not cross the BBB, was systemically administered to cortical graft-bearing hosts in order to determine if a barrier to small potentially bioactive compounds was present. Postoperative periods ranged between 1 week and 15 months for the cortical grafts and between 1 week and 8 months for nigral grafts; the experiments were repeated several times at the same time point in order to determine the potential for variability in the model systems. The results show that a high percentage (80%) of both neocortical and nigral grafts lack a complete BBB to protein up to 2-3 weeks postoperative. After this time the majority of neocortical grafts were impermeable to protein yet 20-30% of longer-term specimens showed variable degrees of permeability to protein; permeability to [3H]GABA, which manifested in the transmitter being sequestered by graft neurons, was observed only up to 4 weeks postoperative. Nigral grafts after 4 weeks postoperative showed negligible permeability to serum protein. Although in all early CNS grafts protein permeation is extensive in both graft and adjacent host, the mature host brain resolved the exudation far more efficiently so that the reaction appeared exclusively in the graft or interface and not in the host by 2-3 weeks, suggesting that the graft tissue may lack appropriate mechanisms for clearance of extracellular materials. It is unclear why this phenomenon occurred consistently but in a minority percentage of cortical specimens. It is suggested that either frank pathology or immunopathology provides a subtle and incomplete rejection process that allows the interface vessel to be permeable over the life of the graft. Since nigral grafts appeared to have significantly less BBB dysfunction variation it is possible that the maturation levels or the ontogeny between different graft sources may play a role in differing responses to injury or vascular problems after transplant surgery.
在本研究中,将大鼠胎儿新皮质或黑质的实体移植物移植到成年幼鼠的皮质或纹状体中。为了研究血脑屏障(BBB)对蛋白质的通透性及潜在变化,通过血管内注射辣根过氧化物酶(HRP),或者为检测内源性蛋白质渗出情况,在对大鼠血清白蛋白进行免疫细胞化学染色后对未注射的动物进行评估。此外,向接受皮质移植物的宿主全身给予[3H]GABA(一种不能穿过血脑屏障的神经递质),以确定是否存在对潜在生物活性小分子的屏障。皮质移植物的术后时间为1周 至15个月,黑质移植物的术后时间为1周 至8个月;在同一时间点重复进行多次实验,以确定模型系统中变异性的可能性。结果表明,高达术后2至3周时,新皮质和黑质移植物中高达80%缺乏完整的血脑屏障对蛋白质的屏障作用。在此之后,大多数新皮质移植物对蛋白质不可渗透,但20%至30%的长期标本显示出不同程度的蛋白质通透性;对[3H]GABA的通透性仅在术后4周内观察到,表现为递质被移植物神经元摄取。术后4周后,黑质移植物对血清蛋白的通透性可忽略不计。尽管在所有早期中枢神经系统移植物中,蛋白质在移植物和相邻宿主中均有广泛渗透,但成熟的宿主脑能更有效地解决渗出问题,因此到2至3周时,反应仅出现在移植物或界面处,而不在宿主中,这表明移植物组织可能缺乏清除细胞外物质的适当机制。目前尚不清楚为什么这种现象在少数皮质标本中持续出现。有人认为,明显的病理学或免疫病理学提供了一个微妙且不完全的排斥过程,使得界面血管在移植物的整个生命周期内都具有通透性。由于黑质移植物似乎血脑屏障功能障碍的变异性明显较小,不同移植物来源之间的成熟水平或个体发育可能在移植手术后对损伤或血管问题的不同反应中起作用。